SHILPAMED Financial Statements

SHILPAMED Half Yearly Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth (0.70) 15.10 1.24 8.76
Op profit growth (17) 35.50 (5.30) 7.06
EBIT growth (18) 31.60 (8.50) 9.26
Net profit growth (5.40) 48.40 (2.20) (0.70)
Profitability ratios (%)        
OPM 20.20 24.20 20.60 22
EBIT margin 17.50 21.30 18.60 20.60
Net profit margin 16.40 17.20 13.30 13.80
RoCE 7.45 12.10 10.90 14.10
RoNW 2.63 3.23 2.54 3.29
RoA 1.74 2.45 1.96 2.37
Per share ratios ()        
EPS 17.90 19 12.60 13
Dividend per share 1.10 1.10 0.70 0.60
Cash EPS 11.50 13.80 8.34 9.60
Book value per share 181 163 133 123
Valuation ratios        
P/E 18.60 12.90 36.80 48.80
P/CEPS 29 17.70 55.70 66.20
P/B 1.84 1.50 3.49 5.16
EV/EBIDTA 16.30 9.88 21.30 27.40
Payout (%)        
Dividend payout -- -- 6.53 5.38
Tax payout (36) (18) (24) (27)
Liquidity ratios        
Debtor days 95.10 93.90 90.50 59.80
Inventory days 110 83.40 87.60 82.60
Creditor days (61) (63) (65) (64)
Leverage ratios        
Interest coverage (7.20) (42) (55) (51)
Net debt / equity 0.49 0.26 0.11 0.14
Net debt / op. profit 3.97 1.57 0.72 0.82
Cost breakup ()        
Material costs (30) (31) (45) (48)
Employee costs (26) (22) (19) (16)
Other costs (24) (24) (15) (14)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 901 908 789 779
yoy growth (%) (0.70) 15.10 1.24 8.76
Raw materials (271) (278) (356) (372)
As % of sales 30 30.60 45.10 47.70
Employee costs (235) (197) (149) (128)
As % of sales 26.10 21.70 18.90 16.40
Other costs (213) (214) (122) (108)
As % of sales 23.70 23.50 15.40 13.90
Operating profit 182 220 162 171
OPM 20.20 24.20 20.60 22
Depreciation (54) (44) (37) (31)
Interest expense (22) (4.60) (2.70) (3.10)
Other income 30.10 16.90 21.70 19.70
Profit before tax 136 188 144 157
Taxes (49) (33) (34) (42)
Tax rate (36) (18) (24) (27)
Minorities and other 1.58 1.59 2.38 3.12
Adj. profit 88.70 157 112 118
Exceptional items 60.80 -- -- (4.50)
Net profit 148 156 105 108
yoy growth (%) (5.40) 48.40 (2.20) (0.70)
NPM 16.40 17.20 13.30 13.80
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 136 188 144 157
Depreciation (54) (44) (37) (31)
Tax paid (49) (33) (34) (42)
Working capital 572 278 245 --
Other operating items -- -- -- --
Operating cashflow 605 390 318 84.50
Capital expenditure 973 510 18.30 --
Free cash flow 1,578 899 336 84.50
Equity raised 1,713 1,705 1,618 1,856
Investments 10.90 (55) 87.40 --
Debt financing/disposal 827 264 49.20 15.70
Dividends paid -- -- 6.87 5.79
Other items -- -- -- --
Net in cash 4,129 2,813 2,098 1,962
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 8.15 8.15 8.15 8.15
Preference capital -- -- -- --
Reserves 1,471 1,321 1,189 1,077
Net worth 1,479 1,329 1,198 1,085
Minority interest
Debt 844 390 194 191
Deferred tax liabilities (net) 112 101 101 97
Total liabilities 2,424 1,813 1,485 1,368
Fixed assets 1,652 1,317 987 744
Intangible assets
Investments 21.20 10.50 2.26 140
Deferred tax asset (net) 64.80 59.20 53.50 37.70
Net working capital 563 382 348 372
Inventories 317 226 188 189
Inventory Days 128 91 -- 87.30
Sundry debtors 223 247 204 220
Debtor days 90.20 99.20 -- 102
Other current assets 302 144 135 132
Sundry creditors (114) (127) (100) (110)
Creditor days 46 50.90 -- 50.90
Other current liabilities (165) (109) (78) (59)
Cash 123 44.60 94.50 73.80
Total assets 2,424 1,813 1,485 1,368
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2022 Sep-2021 Mar-2021 Sep-2020 Mar-2020
Gross Sales 613 533 399 502 457
Excise Duty -- -- -- -- --
Net Sales 613 533 399 502 457
Other Operating Income -- -- -- -- --
Other Income 10.90 12.20 15.50 75.50 9.14
Total Income 624 545 415 577 466
Total Expenditure ** 496 449 353 368 334
PBIDT 128 95.30 61.60 209 132
Interest 19.30 21.90 13.90 7.96 2.28
PBDT 109 73.40 47.70 201 130
Depreciation 43 36.80 29 25 22.50
Minority Interest Before NP -- -- -- -- --
Tax 17.80 16.20 8.97 36.30 23.20
Deferred Tax 8.74 (1.10) (5.30) 8.87 (5)
Reported Profit After Tax 39.10 21.50 15 131 89.10
Minority Interest After NP -- (0.10) (1.10) (0.50) (0.50)
Net Profit after Minority Interest 39.10 21.60 16.10 132 89.60
Extra-ordinary Items (0.10) 4.96 -- 45.30 --
Adjusted Profit After Extra-ordinary item 39.20 16.60 16.10 86.40 89.60
EPS (Unit Curr.) 4.51 2.64 1.97 16.20 11
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 8.68 8.15 8.15 8.15 8.15
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 20.90 17.90 15.40 41.70 28.90
PBDTM(%) -- -- -- -- --
PATM(%) 6.38 4.04 3.76 26.10 19.50
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity